BioSpace News Archive

Each year, more Americans are diagnosed with excess weight or obesity as well as many of the more than 50 diseases related to obesity such as type 2 diabetes, hypertension, sleep apnea and heart disease

As the consumer trend of demanding premium-quality apparel for multi-use is on the rise, more brands are partnering with Noble Biomaterials, a global leader in odor elimination and smart fabric solutions, to develop products with Noble’s platform of inherent fiber technologies – allowing them to stay current in the ever-evolving apparel industry.

The American Pharmacists Association (APhA) congratulates James W. Carroll upon his swearing in as the Director of the Office of the National Drug Control Policy (ONDCP), our nation’s “Drug Czar.”

“I wanted to create a mobility aid that provides added support and assistance for users and also gives users the confidence to go out on their own,” said an inventor, from Le Sueur, Minn., “so I invented the CANE BUDDY.”

Today, Cook Medical announced its recent approval from the U.S. FDA for its Zenith Dissection Endovascular System

UnitedHealthcare’s new insulin pump agreement with Medtronic is an unacceptable step backward in giving children with type 1 diabetes (T1D) what they need to manage their disease and stay health

Giving customers the latest tools to improve workflow and image quality, Canon Medical Systems is rolling out new enhancements to its Celesteion™ PET/CT system.

Mercy Air, a division of Air Methods, announced the opening of Mercy Air 66, a new base that will provide air medical services to the Barstow community.

The round will focus on the development of both Healthware’s core business and the digital health consultancy and product factory activities

Akebia Therapeutics, Inc. granted 11 newly-hired employees options to purchase an aggregate of 41,900 shares of Akebia’s common stock on January 31, 2019, as inducements material to each such employee’s entering into employment with Akebia.